These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10238654)

  • 1. Prescription drug dispensing container requirements: final rule.
    Fed Regist; 1978 Aug; 43(166):37985-9. PubMed ID: 10238654
    [No Abstract]   [Full Text] [Related]  

  • 2. Requirements for dispensing containers for prescription drugs; stay of effective date.
    Fed Regist; 1979 Aug; 44(156):47042-3. PubMed ID: 10242806
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record.
    Fed Regist; 2000 May; 65(86):25639-41. PubMed ID: 11010689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(35):8105-7. PubMed ID: 14997866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amendment of regulations regarding certain label statements on prescription drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(22):4904-7. PubMed ID: 11829025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relief in tamper-resistant packages.
    Hopkins H
    FDA Consum; 1983 Feb; 17(1):12-6. PubMed ID: 10309982
    [No Abstract]   [Full Text] [Related]  

  • 12. Advice for the dispensing physician.
    Blake MI; Slotnik LB
    IMJ Ill Med J; 1980 Aug; 158(2):65-8. PubMed ID: 6105145
    [No Abstract]   [Full Text] [Related]  

  • 13. The prescription drug marketing act: a solution in search of a problem?
    Angarola RT; Beach JE
    Food Drug Law J; 1996; 51(1):21-55. PubMed ID: 11794352
    [No Abstract]   [Full Text] [Related]  

  • 14. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal problems in psychiatric drug prescription.
    Appleton WS
    Am J Psychiatry; 1968 Jan; 124(7):877-82. PubMed ID: 5688683
    [No Abstract]   [Full Text] [Related]  

  • 17. The status of unit-of-use in Europe and the United States: an evolution in drug dispensing.
    Archambault GF
    Hosp Formul; 1979 Jan; 14(1):70-1, 75-6, 78-9. PubMed ID: 10297341
    [No Abstract]   [Full Text] [Related]  

  • 18. The variability and quality of medication container labels.
    Shrank WH; Agnew-Blais J; Choudhry NK; Wolf MS; Kesselheim AS; Avorn J; Shekelle P
    Arch Intern Med; 2007 Sep; 167(16):1760-5. PubMed ID: 17846395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice.
    Fed Regist; 1982 Sep; 47(173):39249-50. PubMed ID: 10258155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exemption of antibiotic drugs and antibiotic susceptibility medical devices from certification--Food and Drug Administration. Proposed rule.
    Fed Regist; 1982 May; 47(89):19954-60. PubMed ID: 10255457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.